Clinical Trial Update: Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing weekly versus every 3-week chemotherapy regimens in patients with ovarian cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Ovarian Cancer | Phase 3 | Status: UNKNOWN